DLL4-overexpressing tumours have increased perfusion and are insensitive to BEV treatment, as described previously.14 Importantly, endothelial FABP4 expression was insensitive to VEGFA inhibition alone, but was reduced when inhibition of NOTCH1 and VEGFA signalling was combined. This evidence concerns the gene DLL4 and neoplasm.